An in-depth look to REGENERON PHARMAC.DL-,001 operating, investing, and financing activities

RGO free cash flow for Q4 24 is 1.03 B EUR. For 2024, RGO free cash flow was 3.54 B EUR and operating cash flow was 4.27 B EUR.